Panacea Biotec share news, announcements and annual reports
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Panacea Biotec Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹313.25down ₹12.65 (3.88%)BSE ₹312.95
Share price at the NSE close on 30 Oct 2026. Previous close ₹325.90.
30 Oct: open ₹323.05, high ₹325.95, low ₹311.10
52-week range of traded prices to 30 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,919 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.30
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 57,86658.2% delivered
Panacea Biotec share news and announcements
875 announcements, routine notices left out, newest first. Page 16 of 18.
Oct 2010
Sep 2010
29 Sep · Management
Mr. Gurmeet Singh, Non-Executive Director has ceased to be the Director of the Company w.e.f. September 25, 2010. The members present at the Annual General Meeting held on September 25, 2010 have decided not to fill the vacancy caused by his retirement by rotation pursuant to Section 256 of the Companies Act, 1956.
Aug 2010
25 Aug · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2010
20 Jul · Meeting
Board of Directors, at their meeting held on July 20, 2010 has decided as under: i) the Annual General Meeting of the Company has been convened to be held on September 25, 2010, and ii) the Register of Members and Share Transfer Books will remain closed from September 20, 2010 to September 25, 2010 (both days inclusive) for the purpose of Annual General Meeting and ascertaining the list of members entitled to receive the dividend on Equity share, if any, declared at the said meeting.12 Jul · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter ended June 30, 2010.
May 2010
7 May · Dividend
Board of Directors at its meeting held on May 07, 2010 has recommended dividend of Re.0.25 (25%) each on Equity Shares of the Company, for the financial year 2009-10. The total amount of dividend payable, if approved by Shareholders, shall be Rs.16.7 million, excluding dividend distribution tax.
Apr 2010
30 Apr · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated April 30, 2010, titled "'State of the Art' Pharmaceutical Formulation Facility Gets USFDA approval". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Apr · Board meeting
To inter-alia, consider and approve the Audited Financial Results for the Financial year 2009-10 and to recommend dividend, if any, on the share capital of the Company.
Mar 2010
22 Mar · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated March 22, 2010, titled "Panacea Biotec wins financial assistance award for PandyFlu TM (Swine Flu vaccine)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Mar · Resolution passed by the shareholders
Panacea Biotec Ltd. has informed the Exchange regarding the result of Postal Ballot Notice dated January 21, 2010 whereby Shareholders have approved the proposed special resolution for Buy-back of the Company's own fully paid-up 5,592,000 Equity shares of Re.1 each at a price not exceeding Rs.229 per share by way of Open Market Purchase through Stock Exchanges. Further a copy of the said Special Resolution approved by the shareholders shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Mar · Results
Panacea Biotec Ltd. has informed the Exchange that the result for the resolution proposed by the postal ballot in relation to the Special Resolution proposed to be passed under Section 77A of the Companies Act, 1956 and Securities & Exchange Board of India (Buy Back of Securities) Regulations, 1998 for the Buy Back of 5,592,000 Equity Shares of the Company at a price not exceeding Rs. 229 per equity share with total aggregate amount to be expended not to exceed Rs. 1,280,568,000 vide Postal Ballot Notice dated January 21, 2010 has been approved by the overwhelming majority. The results of the voting conducted through Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Mar · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated March 03, 2010, titled " Panacea Biotec to meet Swine Flu vaccination demand- Signs Advance Market Commitment Agreement with Govt. of India". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Mar · Updates
Panacea Biotec Ltd. has submitted to the Exchange a copy of the Clarification with regard to investors' Queries relating to: (1) Recent News items appeared in newspapers in respect of Pentavalent Vaccine. (2) Buyback of Shares. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2010
11 Feb · Results
Panacea Biotec Ltd. has informed the Exchange regarding the Result of Postal Ballot for passing the Special Resolution under Section 77A of the Companies Act, 1956 and Securities & Exchange Board of India (Buy back of Securities) Regulations, 1998 for the Buy-back of 5,592,000 Equity Shares of the Company at a price not exceeding Rs.189 per Equity Share with the total aggregate amount to be expended not to exceed Rs.1,056,888,000, which has not been approved by the shareholders with the requisite majority. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Feb · Meeting
Panacea Biotec Ltd. has informed the Exchange that as per Section 192A of the Companies Act, 1956, read with the Companies (Passing of the Resolutions by Postal Ballot) Rules, 2001, for passing the following resolutions: Special Resolution under Section 77A of the Companies Act, 1956 and Securities & Exchange Board of India (Buy Back of Securities ) Regulations, 1998 for the Buy Back of 5,592,000 Equity Shares of the Company at a price not exceeding Rs. 229 per Equity Share with the total aggregate amount to be expended not to exceed Rs. 1,280,568,000/-. A copy of the notice of postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Feb · Limited Review Report
Panacea Biotec Ltd. has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
29 Jan · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated January 29, 2010, titled "Panacea Biotec reports impressive financial results for the Quarter & Nine Months ended December 31, 2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Jan · Buy back
Panacea Biotec Ltd. has submitted to the Exchange copy of Board Resolution in respect of Buy-back of Equity shares passed by the Board of Directors in its meeting held on January 21, 2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jan · Board meeting
Panacea Biotec Ltd. has informed the Exchange regarding the outcome of Board Meeting held on January 21, 2010 to review & reconsider the terms of proposed Buyback of Equity shares. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jan · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter as well as nine months ended December 31, 2009.18 Jan · Board meeting
To inter-alia, consider and approve the revised terms & conditions of the proposed buy-back of its Equity Shares. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Jan · Meeting
Panacea Biotec Ltd. has informed the Exchange that as per Section 192A of the Companies Act, 1956, read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2001 ("Postal Ballot Rules") consent of the Members for buying back the equity shares under Section 77A of the Companies Act, 1956 is required to be obtained by means of voting by Postal ballot. A copy of the notice of postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Jan · Updates
Panacea Biotec Ltd. has submitted to the Exchange a certified copy of the resolution passed by the Board of Directors in respect of Buy-back of Equity Shares. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2009
30 Dec · Buy-back/others
Panacea Biotec Ltd. has informed the Exchange that the Board of Directors of the Company has, at its meeting held today i.e. December 30, 2009, inter-alia, considered and approved the buy-back of its Equity Shares of Re. 1/- each, by way of Open Market Purchases through Stock Exchanges, subject to the approval of Shareholders by way of Postal Ballot and exemption by SEBI under the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997. The Board has also, inter-alia, decided on the following: (i) Appointment of M/s. SPA Merchant Bankers Ltd. as the Merchant Bankers for the proposed buy-back of Equity Shares. (ii) Approved maximum buy-back price as Rs. 189/- per Share. (iii) Approved the notice of Postal Ballot for obtaining the approval of Shareholders for buy-back of Equity Shares. (iv)The maximum number of shares proposed for buy-back as 55,92,000 Equity Shares for an aggregate amount not exceeding Rs. 105.69 Crore.24 Dec · Board meeting
To inter-alia, consider and approve the buy-back of its Equity Shares pursuant to the applicable provisions of Companies Act, 1956 and SEBI (Buy-back of Securities) Regulations 1998.
Oct 2009
29 Oct · Limited Review Report
Panacea Biotec Ltd. has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Oct · Business
Panacea Biotec Ltd. has informed the Exchange regarding a press release dated October 29, 2009, titled "Panacea Biotec reports financial results for the Quarter & Half year ended September 30, 2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Oct · Board meeting
To inter-alia, consider and approve the Unaudited Financial Results (Provisional) for the quarter as well as half-year ended September 30, 2009.15 Oct · Rating
Panacea Biotec Ltd. has informed the Exchange regarding "CARE Rating -'PR 1' Commercial Papers". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Oct · Meeting
Panacea Biotec Ltd. has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on September 25, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
4 Sep · Meeting
Panacea Biotec Ltd. has submitted to the Exchange a copy of Notice of the Annual General Meeting of the Members of the Company scheduled to be held on September 25, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.